Screener
Metagenomi Therapeutics, Inc. MGX Q4 2025 Annual earnings
Reported March 5, 2026 · Before market open
Revenue$3.9MMiss by $3.4M
EPS-$0.60Miss by $0.02
Revenue estimate$7.3M
EPS estimate-$0.58
Next report
Nov 10, 2026 (in 2 months)Revenue estimate$2.6M
EPS estimate-$0.64
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Metagenomi Therapeutics, Inc. report Q4 2025 earnings?
- Metagenomi Therapeutics, Inc. (MGX) reported Q4 2025 earnings on March 5, 2026 before market open.
- What were Metagenomi Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Metagenomi Therapeutics, Inc. reported revenue of $3.9M and eps of $-0.60 for Q4 2025.
- Did Metagenomi Therapeutics, Inc. beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $7.3M by $3.4M. EPS missed the consensus estimate of $-0.58 by $0.02.
- How did Metagenomi Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 59.3% from $9.6M a year earlier and eps grew 4.8% from $-0.63.
- Where can I find Metagenomi Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-093943) and the 10-K periodic report (0001193125-26-093976) directly on SEC EDGAR. The filing index links above go to sec.gov.
